LPIN1 rhabdomyolysis: A single site cohort description and treatment recommendations

Reue, 2009, The lipin family: mutations and metabolism, Curr. Opin. Lipidol., 20, 165, 10.1097/MOL.0b013e32832adee5

Zeharia, 2008, Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood, Am. J. Human Genet., 83, 489, 10.1016/j.ajhg.2008.09.002

Michot, 2010, LPIN1 gene mutations: a major cause of severe rhabdomyolysis in early childhood, Hum. Mutat., 31, E1564, 10.1002/humu.21282

Meijer, 2015, LPIN1 deficiency with severe recurrent rhabdomyolysis and persistent elevation of creatine kinase levels due to chromosome 2 maternal isodisomy, Mol. Genet. Metabol. Rep., 5, 85, 10.1016/j.ymgmr.2015.10.010

Bergounioux, 2012, Fatal rhabdomyolysis in 2 children with LPIN1 mutations, J. Pediatr., 160, 1052, 10.1016/j.jpeds.2012.02.033

Stepien, 2019, Long-term outcomes in a 25-year-old female affected with lipin-1 deficiency, JIMD Rep., 46, 4, 10.1002/jmd2.12016

Jaradat, 2016, Molecular analysis of LPIN1 in Jordanian patients with rhabdomyolysis, Meta Gene, 7, 90, 10.1016/j.mgene.2015.12.003

Lutkewitte, 2020, Regulation of signaling and metabolism by lipin-mediated phosphatidic acid phosphohydrolase activity, Biomolecules, 10, 10.3390/biom10101386

Zhang, 2017, Lipin proteins and glycerolipid metabolism: roles at the ER membrane and beyond, Biochim. Biophys. Acta Biomembr., 1859, 1583, 10.1016/j.bbamem.2017.04.007

Summerlin, 2021, Use of dexamethasone in idiopathic, acute pediatric rhabdomyolysis, Am. J. Med. Genet. A, 185, 500, 10.1002/ajmg.a.62000

Zhang, 2014, Lipin-1 regulates autophagy clearance and intersects with statin drug effects in skeletal muscle, Cell Metab., 20, 267, 10.1016/j.cmet.2014.05.003

Indika, 2020, Lipin-1 deficiency-associated recurrent rhabdomyolysis and exercise-induced myalgia persisting into adulthood: a case report and review of literature, Case Rep. Med., 2020, 10.1155/2020/7904190

Tsalikian, 1984, Glucose production and utilization in children with glycogen storage disease type I, Am. J. Physiol., 247, E53

Long, 2019, An evidence-based narrative review of the emergency department evaluation and management of rhabdomyolysis, Am. J. Emerg. Med., 37, 518, 10.1016/j.ajem.2018.12.061

Pichler, 2015, A novel therapeutic approach for LPIN1 mutation-associated rhabdomyolysis, Austr. Exp. Muscle Nerve, 52, 437, 10.1002/mus.24749

Palmer, 2021, Clinical management of hyperkalemia, Mayo Clin. Proc., 96, 744, 10.1016/j.mayocp.2020.06.014

Burstal, 2018, Volatile anesthesia for a child with LPIN1 gene mutation and recurrent rhabdomyolysis, Paediatr. Anaesth., 28, 813, 10.1111/pan.13445

Che, 2020, A rare case of pediatric recurrent rhabdomyolysis with compound heterogenous variants in the LPIN1, BMC Pediatr., 20, 218, 10.1186/s12887-020-02134-5

Topal, 2020, A neglected cause of recurrent rhabdomyolysis, LPIN1 gene defect: a rare case from Turkey, Turk. J. Pediatr., 62, 647, 10.24953/turkjped.2020.04.015